Economic realities: Pharma leadership is often conditioned for the "high-risk, high-reward" physics of pipeline assets. MedTech operates on iterative innovation and service-heavy models. Bridging ...

Qatar is fast emerging as a global leader in precision medicine, powered by more than a decade of strategic investment in gen ...

Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...

Enable more effective and targeted treatments that address unique needs for patients with pharmacogenomics. The traditional one-size-fits-all approach to medication has long been recognized as a ...

A growing number of companies offer the enticing promise of optimizing one’s health by tapping into powerful technology they say can map out what diseases a person is susceptible to and possibly catch ...

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the world's more diverse ...

Ancestry-specific biomarkers, such as POLB, could reshape diagnostic and prognostic approaches in head and neck cancer. New ...

An overarching goal within modern medicine is to increase efficacy of treatment whilst decreasing off-target effects. In recent years, this has manifested through targeted therapies for many disease ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. No two people are the same. Precision medicine, sometimes ...

Editor's note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. Precision medicine in IBD, we're not there ...

Editor's Note: This story was initially published May 21. It was updated June 7 with IPO pricing information. Three years after talks of an IPO surfaced, health tech company Tempus AI lit the fuse and ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...